In this presentation given at Ending Age-Related Diseases 2020, Dr. Isabelle Schiffer of the Forever Healthy Foundation discusses the state of rejuvenation therapies and progress in bringing them into clinical practice. She discusses the rejuvenation market along with senotherapies, which target senescent cells in order to treat age-related diseases. This presentation featured the dasatinib + quercetin senolytic combination along with the supplement fisetin. As she explains, the problems with senolytics as a clinical therapy, as things stand today, are that there are no treatment protocols and no clinical endpoints.
HELP SPREAD THE WORD
Please connect with us on social media, like and share our content, and help us build grass-roots support for healthy life extension:
Researchers publishing in GeroScience have found that carotid artery stenosis, a consequence of hypertension, is linked to a lack of blood flow in the eyes. A disease that restricts blood flow to the brain Carotid artery […]
Dr. Matt Kaeberlein and colleagues recently published a review summarizing anti-aging diets as well as their misconceptions [1]. Caloric restriction, fasting-mimicking […]
A new publication in Nature Aging has investigated the role of the gut bacteria Bifidobacterium adolescentis in aging and longevity. The aging gut microbiome The gut microbiome, previously thought to be […]
Scientists have confirmed yet another positive effect of metformin: its prolonged use by people with diabetes lowers the risk of cognitive impairment and cerebral small vessel disease [1]. A meta-drug? Metformin is one […]
A team of researchers publishing in Cell Death & Disease has found that the age-related decline of mitochondrial calcium uptake family member 3 (MICU3), a […]
You have 3 free articles remaining this week. You can register for free to continue enjoying the best in rejuvenation biotechnology news. Already registered? Login here.
Write a comment: